An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease Justin R. Chen, MD, Brett L. Buchmiller, MD, David A. Khan, MD The Journal of Allergy and Clinical Immunology: In Practice Volume 3, Issue 6, Pages 926-931.e1 (November 2015) DOI: 10.1016/j.jaip.2015.06.013 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 1 Proportion of patients with either naso-ocular or bronchial reactions during aspirin desensitization therapy, according to historical classification. Class A: no prior reaction, class B: one reaction not requiring ED visit or hospitalization, class C: two or more reactions not requiring ED visit or hospitalization, class D: one or more reactions requiring ED visit and hospitalization. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 926-931.e1DOI: (10.1016/j.jaip.2015.06.013) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions